Tracked provider

Zealthy tirzepatide review

Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

This is a tracked entry: the facts below are what Zealthy publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-07-20). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on Zealthy's own site before you pay.

What it costs

Tirzepatide: $351/mo (starting dose, plus a separate fee, compounded)
What is dispensed: Compounded tirzepatide
Who compounds it: Unspecified

How the program works

Serves 34 states. An online intake is reviewed by a licensed clinician. Does not publish a price until after the intake.

What we like

Serves 34 states — meaningful nationwide footprint
Asynchronous model removes friction for patients who don't want a video visit
Independent licensed prescribers retain full clinical authority

The caveats

Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
Recently rebranded to Gronk Inc. amid active enforcement
FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database

Ready to look at Zealthy directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit Zealthy

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

What it costs

How the program works

What we like

The caveats

Other tirzepatide programs we track